The drug "chondroitin" refers tohigh-molecular polysaccharides belonging to the group of glycosaminoglycans or proteoglycans. This agent is chemically highly similar to the structure of the cells that make up cartilage tissues. The biologically active supplement "Chondroitin", the instruction to which describes the therapeutic effect produced by it on the body, activates the process of fixing sulfur, which contributes to the deposition of calcium in bone tissue during the synthesis of chondroitinsulfuric acid. The drug has an effect that allows you to actively carry out the recovery processes in the cartilage.
In addition, the drug "Chondroitin", an instruction forwhich indicates its belonging to chondroprotective agents, is able to protect the meniscus tissue. From the remaining proteoglycans, the drug is distinguished by its ability to conserve water in the cartilage in special microspaces called water cushions. These cavities create a shock-absorbing effect, absorbing impacts. In turn, this increases the strength of connective tissue.
The production of chondroitin in the body is performed inarticular bags filled with synovial fluid. Reducing the amount of this important element in the cartilage worsens the quality of the substance filling it. In this case, the movement is able to cause a crunch of joints. The use of the biologically active additive "Chondroitin", the tablets of which, thanks to the active substance, stimulate the synthesis of hyaluronic acid, allows to strengthen the formations and connective tissue elements, which include cartilage, ligaments and tendons. A very important quality of the drug is its effect on the deactivation of lysosomal enzymes. These substances are released during the decomposition of chondrocytes and destroy connective tissues. The drug helps to reduce pain in the spine and in the joints both at rest and during walking. The drug produces an effect aimed at providing anti-inflammatory and analgesic effects.
The biologically active additive "Chondroitin", the instruction for its use gives the main indications for use, is recommended in the following cases:
- in conditions characterized by a deficiency of chondroitin in the body;
- in the presence of foci of pathology in connective tissues;
- for the treatment of periodontitis, which are acute;
- with existing pathologies in cartilage tissue;
- with arthrosis, parodontosis;
- during the period of treatment for osteochondrosis of the spine;
- for the treatment of osteoporosis, uncomplicated pathological fractures;
- with various pathologies of the joints;
- with fractures (as an additional tool that accelerates the recovery process).
The drug "Chondroitin", an instruction to whichexplains its ability to produce an effect with regular use, reduces or completely eliminates the need to prescribe anti-inflammatory non-steroid agents. This greatly improves the health of patients suffering from various ailments of joints and spine of a chronic nature. The drug is recommended for the treatment of pathologies of cartilage tissue, as well as skin, tendons and ligaments. The drug improves the phosphorus-calcium metabolism. The course of treatment lasting two to three months can reduce the risk of degenerative processes in the cartilage and promote its regeneration. Also, regular intake of the drug restores the joints and joint bags. The recommendation of this biologically active additive is equally possible for sports doctors, dermatologists and cosmetologists.
The drug "Chondroitin", an instruction to whichwarns of conditions in which his reception is not recommended, not prescribed for thrombophlebitis, propensity to bleeding, in childhood, pregnant and lactating.
